NCT00851240View on ClinicalTrials.gov

BTT-1023 in Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

BTT-1023

intravenous

DRUG

Placebo

Intravenous

Trial Locations (1)

1612

Sofia, Bulgaria, Sofia

Sponsors
All Listed Sponsors
lead

Biotie Therapies Corp.

INDUSTRY